Inhibition by verapamil of cholecystokinin-enhancement of pancreatic carcinogenesis induced by azaserine in Wistar rats

Cancer Letters

Volumn 105, Issue 1, 1996, Pages 23-27

  Nakaizumi, Akihiko ^a   Uehara, Hiroyuki ^a   Baba, Miyako ^a   Iishi, Hiroyasu ^a   Tatsuta, Masaharu ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Azaserine; Cholecystokinin; Inhibition; Pancreatic carcinogenesis; Verapamil; class glutathione S transferase

Indexed keywords

AZASERINE; CALCIUM CHANNEL BLOCKING AGENT; CHOLECYSTOKININ; CHOLECYSTOKININ OCTAPEPTIDE; GLUTATHIONE TRANSFERASE; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; HISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; RAT;

EID: 0030593506     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04256-5     Document Type: Article

References (17)

1. [1] Howatson, A.G. and Carter, D.C. (1985) Pancreatic carcinogenesis - enhancement by cholecystokinin in the hamsternitrosamine model. Br. J. Cancer, 51, 107-114.
2. [2] Logsdon, C.D. (1986) Stimulation of pancreatic acinar cell growth by CCK, epidermal growth factor, and insulin in vitro. Am. J. Physiol., 251, G487-G494.
3. [3] Smith, J.P., Kramer, S.T. and Cheung, J.Y. (1991) Effects of cholecystokinin on cytosolic calcium in human pancreatic cancer cells. Regul. Pept., 36, 299-310.
4. [4] Chien, J.L. and Warren, J.R. (1988) Free calcium and calmodulin levels in acinar carcinoma and normal acinar cells of rat pancreas. Int. J. Pancreatol., 3, 113-127.
5. [5] Tatsuta, M., Iishi, H., Baba, M., Nakaizumi, A., Uehara, H. and Taniguchi, H. (1990) Effect of calcium channel blockers on gastric carcinogenesis and caerulein enhancement of gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. Cancer Res., 50, 2095-2098.
6. [6] Rao, M.S., Upton, M.P., Subbarao, V. and Scarpelli, D.G. (1982) Two populations of cells with differing proliferative capacities in atypical acinar cell foci induced by 4-hydroxyaminoquinoline-1-oxide in the rat pancreas. Lab. Invest., 46, 527-534.
7. [7] Roebuck, B.D., Baumgartner, K.J. and Thron, C.D. (1984) Characterization of two populations of pancreatic atypical acinar cell foci induced by azaserine in the rat. Lab. Invest., 50, 141-146.
8. [8] Daly, J.M., Tee, L.B.G., Gates, P.S., Morgan, R.G.H. and Yeoh, G.C.T. (1991) Glutathione S-transferase (μ class) as an early marker of azaserine-induced foci in the rat pancreas. Carcinogenesis, 12, 1237-1240.
9. [9] Lin, P.Y., Joag, S.V., Young, J.D., Chang, Y.S., Soong, Y.K. and Kuo, T.T. (1991) Expression of perform by natural killer cells within first trimester endometrium in humans. Biol. Reprod., 45, 698-703.
10. [10] Bax, J., Feringa, A.W., van Garderen-Hoetmer, A., Woutersen, R.A. and Scherer, E. (1986) Adenosine triphosphatase, a new marker for the differentiation of putative pre-cancerous foci induced in rat pancreas by azaserine. Carcinogenesis, 7, 457-462.
11. [11] Siegel, S. (1956) Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill, New York.
12. [12] Miller, Jr., R.G. (1966) Simultaneous Statistical Inference. McGraw-Hill, New York.
13. [13] Lhoste, E.F. and Longnecker, D.S. (1987) Effect of bombesin and caerulein on early stages of carcinogenesis induced by azaserine in the rat pancreas. Cancer Res., 47, 3273-3277.
14. [14] McGuiness, E.E., Morgan, R.G.H. and Levision, D.A. (1981) Interaction of azaserine and raw soya flour on the rat pancreas. Scand. J. Gastroenterol., 16, 49-56.
15. [15] Roebuck, B.D., Kaplita, P.V. and MacMillan, D. (1985) Interaction of dietary fat and soy bean isolate (SBI) on azaserine-induced pancreatic carcinogenesis. Qual, Plant Foods Hum. Nutr., 35, 323-329.
16. [16] Longnecker, D.S., Lhoste, E.F. and Roebuck, B.D. (1987) Enhancement of growth and conversion of phenotype in azaserine-induced acinar cell foci of rats fed FOY-305. Fed. Proc., 46, 586.
17. [17] Buss, W.C., Savage, D.D., Stepanek, J., Little, S.A. and McGuffee, L.J. (1988). Effect of calcium channel antagonists on calcium channel uptake and release by isolated rat cardiac mitochondria. Eur. J. Pharmacol., 152, 247-253.